Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial [corrected] [published erratum appears in LANCET 2006 Oct 21-27;368(9545):1420].

MLA

Keech A, et al. “Effects of Long-Term Fenofibrate Therapy on Cardiovascular Events in 9795 People with Type 2 Diabetes Mellitus (the FIELD Study): Randomised Controlled Trial [Corrected] [Published Erratum Appears in LANCET 2006 Oct 21-27;368(9545):1420].” Lancet, vol. 366, no. 9500, Nov. 2005, pp. 1849–61. EBSCOhost, https://doi.org/10.1016/s0140-6736(05)67667-2.

APA

Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesäniemi YA, Sullivan D, Hunt D, Colman P, d’Emden M, Whiting M, Ehnholm C, Laakso M, & FIELD study investigators. (2005). Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial [corrected] [published erratum appears in LANCET 2006 Oct 21-27;368(9545):1420]. Lancet, 366(9500), 1849–1861. https://doi.org/10.1016/s0140-6736(05)67667-2

Chicago

Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, et al. 2005. “Effects of Long-Term Fenofibrate Therapy on Cardiovascular Events in 9795 People with Type 2 Diabetes Mellitus (the FIELD Study): Randomised Controlled Trial [Corrected] [Published Erratum Appears in LANCET 2006 Oct 21-27;368(9545):1420].” Lancet 366 (9500): 1849–61. doi:10.1016/s0140-6736(05)67667-2.